Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Renal Insufficiency × pomalidomide × Clear all

Phase

Phase 2 2 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 35 Recurrence 7 Neoplasms, Plasma Cell 6 Waldenstrom Macroglobulinemia 3 Neoplasms 3 Sarcoma, Kaposi 2 Lymphoma, Non-Hodgkin 2 Acquired Immunodeficiency Syndrome 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Renal Insufficiency 1 Plasmablastic Lymphoma 1 Optic Nerve Glioma 1 Neurofibromatosis 1 1 Myeloproliferative Disorders 1 Multi-centric Castleman's Disease 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Leukemia, Myeloid, Acute 1 Immunoglobulin Light-chain Amyloidosis 1 Hematologic Neoplasms 1 Epstein-Barr Virus Infections 1 Disease Progression 1 Disease 1 Central Nervous System Neoplasms 1 Burkitt Lymphoma 1 Amyloidosis 1

Interventions

Kidney Transplantation 2 Cyclophosphamide 2 Azacitidine 2 trifluridine tipiracil drug combination 1 trebananib 1 safinamide 1 sacubitril and valsartan sodium hydrate drug combination 1 rubitecan 1 ripretinib 1 regorafenib 1 pomalidomide 1 pevonedistat 1 mirabegron 1 glucarpidase 1 gamma-Glutamyl Hydrolase 1 dabrafenib 1 copanlisib 1 belinostat 1 belantamab mafodotin 1 Whole-Body Irradiation 1 Topotecan 1 Sitagliptin Phosphate 1 Rituximab 1 Pharmacogenomic Testing 1 Paclitaxel 1 Oxaliplatin 1 Methotrexate 1 Leucovorin 1 Duration of Therapy 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01575925 2022-11-04

POM Renal

Celgene

Phase 1 Completed

Multiple Myeloma, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡